Ocean Biomedical Files 2023 10-K

TL;DR

Ocean Biomedical filed its 2023 10-K. Check financials.

AI Summary

Ocean Biomedical, Inc. filed its 10-K for the fiscal year ending December 31, 2023. The company, formerly known as Aesther Healthcare Acquisition Corp. until a name change on February 14, 2023, is involved in the pharmaceutical preparations industry. Its principal business address is located at 515 Madison Ave, Suite 8078, New York, NY 10022.

Why It Matters

This filing provides a comprehensive overview of Ocean Biomedical's financial health and operational status for the past fiscal year, crucial for investors and stakeholders to assess the company's performance and future prospects.

Risk Assessment

Risk Level: medium — As a company in the pharmaceutical preparations sector, Ocean Biomedical faces inherent risks related to research, development, regulatory approvals, and market competition.

Key Numbers

• 2023-12-31 — Fiscal Year End (Reporting period for the 10-K)
• 2024-11-25 — Filing Date (Date the 10-K was submitted to the SEC)

Key Players & Entities

• Ocean Biomedical, Inc. (company) — Filer of the 10-K
• Aesther Healthcare Acquisition Corp. (company) — Former name of Ocean Biomedical, Inc.
• 2023-12-31 (date) — Fiscal year end
• 2024-11-25 (date) — Filing date
• 515 Madison Ave Suite 8078 (address) — Business and mailing address
• New York, NY 10022 (address) — Business and mailing address

FAQ

Key Financial Figures

• $0.0001 — ch registered Common stock, par value $0.0001 per share OCEA The NASDAQ Stock Mar
• $11.50 — of common stock at an exercise price of $11.50 OCEAW The NASDAQ Stock Market LLC
• $6.01 — 30, 2023, based on the closing price of $6.01 for shares of the registrant's common s

Filing Documents

• form10-k.htm (10-K) — 3103KB
• ex31-1.htm (EX-31.1) — 18KB
• ex31-2.htm (EX-31.2) — 18KB
• ex32-1.htm (EX-32.1) — 8KB
• ex32-2.htm (EX-32.2) — 8KB
• form10-k_001.jpg (GRAPHIC) — 86KB
• form10-k_002.jpg (GRAPHIC) — 117KB
• form10-k_003.jpg (GRAPHIC) — 31KB
• form10-k_004.jpg (GRAPHIC) — 27KB
• form10-k_005.jpg (GRAPHIC) — 19KB
• form10-k_006.jpg (GRAPHIC) — 17KB
• form10-k_007.jpg (GRAPHIC) — 23KB
• form10-k_008.jpg (GRAPHIC) — 14KB
• form10-k_009.jpg (GRAPHIC) — 24KB
• form10-k_010.jpg (GRAPHIC) — 20KB
• form10-k_011.jpg (GRAPHIC) — 11KB
• form10-k_012.jpg (GRAPHIC) — 17KB
• form10-k_013.jpg (GRAPHIC) — 20KB
• form10-k_014.jpg (GRAPHIC) — 19KB
• form10-k_015.jpg (GRAPHIC) — 12KB
• form10-k_016.jpg (GRAPHIC) — 5KB
• form10-k_017.jpg (GRAPHIC) — 6KB
• form10-k_018.jpg (GRAPHIC) — 30KB
• 0001493152-24-047661.txt ( ) — 10915KB
• ocea-20231231.xsd (EX-101.SCH) — 67KB
• ocea-20231231_cal.xml (EX-101.CAL) — 58KB
• ocea-20231231_def.xml (EX-101.DEF) — 319KB
• ocea-20231231_lab.xml (EX-101.LAB) — 521KB
• ocea-20231231_pre.xml (EX-101.PRE) — 424KB
• form10-k_htm.xml (XML) — 1109KB

Business

Business 9 ITEM 1A.

Risk Factors

Risk Factors 67 ITEM 1B. Unresolved Staff Comments 133 ITEM 2.

Properties

Properties 133 ITEM 3.

Legal Proceedings

Legal Proceedings 133 ITEM 4. Mine Safety Disclosures 133 PART II ITEM 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 134 ITEM 6. [Reserved.] 136 ITEM 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 136 ITEM 7A.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk ITEM 8. Financial ITEM 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure ITEM 9A. Controls and Procedure ITEM 9B. Other Information 160 ITEM 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections. 160 PART III ITEM 10. Directors, Executive Officers and Corporate Governance 161 ITEM 11.

Executive Compensation

Executive Compensation 161 ITEM 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 161 ITEM 13. Certain Relationships and Related Transactions, and Director Independence 161 ITEM 14. Principal Accounting Fees and Services 167 PART IV ITEM 15. Exhibits and Financial Statement Schedules 168 ITEM 16. Form 10-K Summary 176 2 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS Certain and Analysis of Financial Condition and Results of Operations," are "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and are being made pursuant to the safe harbor provisions contained therein. These forward-looking statements relate to current expectations and strategies, future operations, future financial positioning, future revenue, projected costs, prospects, current plans, current objectives of management and expected market growth, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from expectations, estimates, and projections expressed or implied by these forward-looking statements and, consequently, you should not rely on these forward-looking statements as a guarantee, an assurance, a prediction or a definitive statement of fact or probability of future events. In some cases, you can identify forward-looking statements through the use of words or phrases such as "may", "should", "could", "predict", "potential", "plan", "seeks", "believe", "will likely result", "expect", "continue", "will continue", "will", "will be", "anticipate", "seek", "estimate", "intend", "plan", "projection", "would", "outlook", and similar expressions, or the negative version of those words or phrases or other comparable words or phrases of a future or forward-looking

View Full Filing

View this 10-K filing on SEC EDGAR